@article {Allan-Blitz2020.12.09.20246249, author = {Lao-Tzu Allan-Blitz and Isaac Turner and Fred Hertlein and Jeffrey D. Klausner}, title = {High Frequency and Prevalence of Community-Based Asymptomatic SARS-CoV-2 Infection}, elocation-id = {2020.12.09.20246249}, year = {2020}, doi = {10.1101/2020.12.09.20246249}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Approximately 20-40\% of SARS-CoV-2 infection is asymptomatic; however, data are limited on drivers of such infection. Among over 730,000 SARS-CoV-2 test results in Los Angeles between August-October, 2020, we found heterogenous frequencies of asymptomatic infection among various sup-populations. Further research is needed to delineate drivers of asymptomatic SARS-CoV-2 infection.Competing Interest StatementDr. Allan-Blitz has served as a consultant for Curative Inc. Dr. Klausner has served as the medical director of Curative Inc. during the observation period. Isaac Turner and Fred Hertlein have served as employees of Curative Inc. during the observation period.Funding StatementThere was no funding for this projectAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mass General Brigham institutional review board deemed the analysis of de-identified data did not constitute human subjects research 2020P003530All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is not available at this time}, URL = {https://www.medrxiv.org/content/early/2020/12/11/2020.12.09.20246249}, eprint = {https://www.medrxiv.org/content/early/2020/12/11/2020.12.09.20246249.full.pdf}, journal = {medRxiv} }